Skip to content
My WebMD Sign In, Sign Up

rifabutin

Interactions

Selected Antineoplastic Systemic Enzyme Inhibitors/Strong 3A4 Inducers

This information is generalized and not intended as specific medical advice. Consult your healthcare professional before taking or discontinuing any drug or commencing any course of treatment.

Medical warning:

Serious. These medicines may interact and cause very harmful effects. Contact your healthcare professional (e.g. doctor or pharmacist) for more information.

How the interaction occurs:

Some medicines may speed up how quickly your liver processes your cancer medicine.

What might happen:

The amount of your cancer medicine in your blood may decrease and it may not work as well.

What you should do about this interaction:

Let your healthcare professionals (e.g. doctor or pharmacist) know that you are taking these medicines together. Your doctor may want to adjust the dose of your cancer medicine.Your healthcare professionals may already be aware of this interaction and may be monitoring you for it. Do not start, stop, or change the dosage of any medicine before checking with them first.

References:

1.Bosulif (bosutinib) US prescribing information. Pfizer Inc. September, 2013.

2.Cometriq (cabozantinib) US prescribing information. Exelixix, Inc. November 29, 2012.

3.Zykadia (ceritinib) US prescribing information. Novartis Pharmaceuticals Corporation April, 2014.

4.Xalkori (crizotinib) US prescribing information. Pfizer Inc. November, 2013.

5.Tafinlar (dabrafenib) US prescribing information. GlaxoSmithKline January, 2014.

6.Sprycel (dasatinib) US prescribing information. Bristol-Myers Squibb Company June, 2013.

7.Tarceva (erlotinib) US prescribing information. Genentech, Inc. April, 2012.

8.Iressa (gefitinib tablets) US prescribing information. AstraZeneca Pharmaceuticals LP April 7, 2004.

9.Imbruvica (ibrutinib) US prescribing information. Janssen Biotech, Inc. November, 2013.

10.Zydelig (idelalisib) US prescribing information. Gilead Sciences, Inc. July, 2014.

11.Gleevec (imatinib mesylate) US prescribing information. Novartis Pharmaceuticals Corporation October, 2013.

12.Tykerb (lapatinib) US prescribing information. GlaxoSmithKline October, 2013.

13.Tasigna (nilotinib) US prescribing information. Novartis Pharmaceuticals Corporation September, 2013.

14.Votrient (pazopanib) US prescribing information. GlaxoSmithKline November, 2013.

15.Nexavar (sorafenib) US prescribing information. Bayer Pharmaceuticals Corporation November, 2013.

16.Sutent (sunitinib malate) US prescribing information. Pfizer Inc. August, 2013.

17.Caprelsa (vandetanib) US prescribing information. AstraZeneca Pharmaceuticals LP July, 2013.

18.Bolton AE, Peng B, Hubert M, Krebs-Brown A, Capdeville R, Keller U, Seiberling M. Effect of rifampicin on the pharmacokinetics of imatinib mesylate (Gleevec, STI571) in healthy subjects. Cancer Chemother Pharmacol 2004 Feb;53(2):102-6.

19.US Food and Drug Administration (FDA). Drug Development and Drug Interactions: Table of Substrates, Inhibitors and Inducers. Available at: http://www.fda.gov/Drugs/DevelopmentApprovalProcess/DevelopmentResources/ DrugInteractionsLabeling/ucm093664.htm. Updated 08/05/2011.

Selected from data included with permission and copyrighted by First Databank, Inc. This copyrighted material has been downloaded from a licensed data provider and is not for distribution, expect as may be authorized by the applicable terms of use.

CONDITIONS OF USE: The information in this database is intended to supplement, not substitute for, the expertise and judgment of healthcare professionals. The information is not intended to cover all possible uses, directions, precautions, drug interactions or adverse effects, nor should it be construed to indicate that use of a particular drug is safe, appropriate or effective for you or anyone else. A healthcare professional should be consulted before taking any drug, changing any diet or commencing or discontinuing any course of treatment.

More about Drugs and Medications

Newsletters

Subscribe to free WebMD newsletters.

  • WebMD Daily

    WebMD Daily

    Subscribe to the WebMD Daily, and you'll get today's top health news and trending topics, and the latest and best information from WebMD.

  • Men's Health

    Men's Health

    Subscribe to the Men's Health newsletter for the latest on disease prevention, fitness, sex, nutrition, and more from WebMD.

  • Women's Health

    Women's Health

    Subscribe to the Women's Health newsletter for the latest on disease prevention, fitness, sex, diet, anti-aging, and more from WebMD.

By clicking Submit, I agree to the WebMD Terms & Conditions & Privacy Policy

URAC: Accredited Health Web Site TRUSTe online privacy certification HONcode Seal AdChoices